BD has expanded a Class I Alaris recall to cover 15 additional pump infusion sets, the company said Friday. The Food and Drug Administration posted the company's notice on Monday. The company added ...
A problem with the keypad overlay could cause fluid ingress which could lead to a keypad malfunction causing the infusion to stop with alarm, an FDA notice in August said. When infusion stops, this ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device ...
FDA has assigned a Class I designation to a recall of CareFusion Alaris infusion pumps, originally announced last month. The agency gave the same designation to a recall of frame membranes that Elite ...
A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.
DUBLIN, Ohio, Feb. 6 (UPI) -- Cardinal Health said Tuesday it has struck an agreement with the U.S. Food and Drug Administration to resume sales of its Alaris SE Infusion Pump. The deal calls for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results